{"id":77162,"date":"2026-11-18T03:28:56","date_gmt":"2026-11-18T03:28:56","guid":{"rendered":"https:\/\/www.stocktargetadvisor.com\/blog\/?p=77162"},"modified":"2026-11-18T03:28:56","modified_gmt":"2026-11-18T03:28:56","slug":"american-analyst-ratings-updates-november-17th-2026","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-17th-2026\/","title":{"rendered":"American Analyst Ratings Updates: November 17th, 2026"},"content":{"rendered":"<h2><a href=\"https:\/\/www.stocktargetadvisor.com\/blog\/?p=77162&amp;preview=true\">Analyst Ratings (USA)<\/a><\/h2>\n<p><strong>American Airlines Group (AAL)<\/strong> \u2014 UBS Group raised its price target from $16.00 to $17.00, maintaining a Buy rating.<\/p>\n<p><strong>Advance Auto Parts (AAP)<\/strong> \u2014 Stifel Nicolaus initiated coverage with a Hold rating and a price target of $47.00.<\/p>\n<p><strong>Ascentage Pharma Group International (AAPG)<\/strong> \u2014 BTIG Research maintained its Buy rating with a price target of $48.00.<\/p>\n<p><strong>Ameris Bancorp (ABCB)<\/strong> \u2014 DA Davidson maintained its Buy rating with a price target of $96.00.<\/p>\n<p><strong>Arch Capital Group (ACGL)<\/strong> \u2014 Morgan Stanley raised its price target from $103.00 to $113.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Albertsons Companies (ACI)<\/strong> \u2014 Stifel Nicolaus initiated coverage with a Hold rating and a price target of $14.00.<\/p>\n<p><strong>AECOM (ACM)<\/strong> \u2014 Robert W. Baird raised its price target from $65.00 to $86.00, maintaining a Neutral rating.<\/p>\n<p><strong>Aclaris Therapeutics (ACRS)<\/strong> \u2014 Canaccord Genuity Group lowered its price target from $13.00 to $12.00, maintaining a Buy rating.<\/p>\n<p><strong>Aclaris Therapeutics (ACRS)<\/strong> \u2014 Wedbush downgraded the stock from Outperform to Neutral and lowered its price target from $8.00 to $3.00.<\/p>\n<p><strong>Acrivon Therapeutics (ACRV)<\/strong> \u2014 Citizens Jmp maintained its Market Outperform rating.<\/p>\n<p><strong>Autodesk (ADSK)<\/strong> \u2014 KeyCorp maintained its Overweight rating.<\/p>\n<p><strong>Atlas Energy Solutions (AESI)<\/strong> \u2014 Glj Research maintained its Buy rating with a price target of $13.00.<\/p>\n<p><strong>Affirm (AFRM)<\/strong> \u2014 Truist Financial lowered its price target from $88.00 to $86.00, maintaining a Buy rating.<\/p>\n<p><strong>Exp World (AGNT)<\/strong> \u2014 StoneX lowered its price target from $6.00 to $5.00, maintaining a Buy rating.<\/p>\n<p><strong>American International Group (AIG)<\/strong> \u2014 Morgan Stanley raised its price target from $80.00 to $85.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>American Integrity Insurance Group (AII)<\/strong> \u2014 Keefe, Bruyette &amp; Woods raised its price target from $31.00 to $34.00, maintaining an Outperform rating.<\/p>\n<p><strong>AirJoule Technologies (AIRJ)<\/strong> \u2014 B. Riley Financial lowered its price target from $8.00 to $6.00, maintaining a Buy rating.<\/p>\n<p><strong>AirJoule Technologies (AIRJ)<\/strong> \u2014 D. Boral Capital maintained its Buy rating with a price target of $8.00.<\/p>\n<p><strong>AirJoule Technologies (AIRJ)<\/strong> \u2014 UBS Group downgraded the stock to Neutral.<\/p>\n<p><strong>Arthur J. Gallagher &amp; Co. (AJG)<\/strong> \u2014 Argus raised its price target from $300.00 to $317.00, maintaining a Buy rating.<\/p>\n<p><strong>Aktis Oncology (AKTS)<\/strong> \u2014 Raymond James Financial maintained its Strong-Buy rating.<\/p>\n<p><strong>Alaska Air Group (ALK)<\/strong> \u2014 UBS Group raised its price target from $48.00 to $54.00, maintaining a Buy rating.<\/p>\n<p><strong>Allstate (ALL)<\/strong> \u2014 Morgan Stanley raised its price target from $260.00 to $275.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Allot (ALLT)<\/strong> \u2014 Freedom Broker lowered its price target from $13.90 to $12.70, maintaining a Buy rating.<\/p>\n<p><strong>Almonty Industries (ALM)<\/strong> \u2014 B. Riley Financial lowered its price target from $20.00 to $18.00, maintaining a Buy rating.<\/p>\n<p><strong>Alnylam Pharmaceuticals (ALNY)<\/strong> \u2014 Cantor Fitzgerald lowered its price target from $290.00 to $205.00, maintaining a Neutral rating.<\/p>\n<p><strong>Alnylam Pharmaceuticals (ALNY)<\/strong> \u2014 HC Wainwright lowered its price target from $455.00 to $250.00, maintaining a Buy rating.<\/p>\n<p><strong>American Homes 4 Rent (AMH)<\/strong> \u2014 Citizens Jmp maintained its Market Outperform rating with a price target of $37.00.<\/p>\n<p><strong>American Tower (AMT)<\/strong> \u2014 Deutsche Bank initiated coverage with a Buy rating and a price target of $222.00.<\/p>\n<p><strong>Amazon.com (AMZN)<\/strong> \u2014 UBS Group initiated coverage with a Buy rating and a price target of $340.00.<\/p>\n<p><strong>Apollo Global Management (APO)<\/strong> \u2014 Mizuho initiated coverage with an Outperform rating and a price target of $145.00.<\/p>\n<p><strong>Ardent Health (ARDT)<\/strong> \u2014 Truist Financial raised its price target from $13.00 to $22.00, maintaining a Buy rating.<\/p>\n<p><strong>Ares Management (ARES)<\/strong> \u2014 Mizuho initiated coverage with an Outperform rating and a price target of $159.00.<\/p>\n<p><strong>Aramark (ARMK)<\/strong> \u2014 UBS Group raised its price target from $65.00 to $68.00, maintaining a Buy rating.<\/p>\n<p><strong>Aramark (ARMK)<\/strong> \u2014 Morgan Stanley lowered its price target from $63.00 to $61.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Aramark (ARMK)<\/strong> \u2014 Robert W. Baird lowered its price target from $69.00 to $65.00, maintaining an Outperform rating.<\/p>\n<p><strong>Aramark (ARMK)<\/strong> \u2014 JPMorgan Chase &amp; Co. lowered its price target from $70.00 to $69.00, maintaining an Overweight rating.<\/p>\n<p><strong>Arrowhead Pharmaceuticals (ARWR)<\/strong> \u2014 Citigroup lowered its price target from $108.00 to $105.00, maintaining a Buy rating.<\/p>\n<p><strong>Amer Sports (AS)<\/strong> \u2014 Jefferies Financial Group maintained its Buy rating.<\/p>\n<p><strong>Ascendis Pharma A\/S (ASND)<\/strong> \u2014 Jefferies Financial Group maintained its Buy rating.<\/p>\n<p><strong>Actinium Pharmaceuticals (ATNM)<\/strong> \u2014 HC Wainwright maintained its Buy rating with a price target of $4.00.<\/p>\n<p><strong>AXT (AXTI)<\/strong> \u2014 B. Riley Financial lowered its price target from $56.00 to $43.00, maintaining a Neutral rating.<\/p>\n<p><strong>Aytu BioPharma (AYTU)<\/strong> \u2014 Maxim Group downgraded the stock from Buy to Hold.<\/p>\n<p><strong>Aytu BioPharma (AYTU)<\/strong> \u2014 Lake Street Capital downgraded the stock from Buy to Hold, with a price target of $2.70.<\/p>\n<p><strong>AutoZone (AZO)<\/strong> \u2014 Stifel Nicolaus initiated coverage with a Hold rating and a price target of $3,450.00.<\/p>\n<p><strong>Bally&#8217;s (BALY)<\/strong> \u2014 Stifel Nicolaus lowered its price target from $13.00 to $12.00, maintaining a Hold rating.<\/p>\n<p><strong>BigBear.ai (BBAI)<\/strong> \u2014 HC Wainwright initiated coverage with a Buy rating and a price target of $4.00.<\/p>\n<p><strong>Best Buy (BBY)<\/strong> \u2014 UBS Group raised its price target from $90.00 to $103.00, maintaining a Neutral rating.<\/p>\n<p><strong>Best Buy (BBY)<\/strong> \u2014 Stifel Nicolaus initiated coverage with a Hold rating and a price target of $100.00.<\/p>\n<p><strong>Portman Ridge Finance (BCIC)<\/strong> \u2014 Oppenheimer lowered its price target from $11.00 to $9.00, maintaining a Market Perform rating.<\/p>\n<p><strong>Franklin Resources (BEN)<\/strong> \u2014 Mizuho initiated coverage with a Neutral rating and a price target of $38.00.<\/p>\n<p><strong>Brookfield Renewable Partners (BEP)<\/strong> \u2014 Morgan Stanley raised its price target from $37.00 to $39.00, maintaining an Overweight rating.<\/p>\n<p><strong>Brookfield Renewable (BEPC)<\/strong> \u2014 Morgan Stanley raised its price target from $37.00 to $39.00, maintaining an Underweight rating.<\/p>\n<p><strong>Baidu (BIDU)<\/strong> \u2014 StoneX lowered its price target from $150.00 to $125.00, maintaining a Buy rating.<\/p>\n<p><strong>Baidu (BIDU)<\/strong> \u2014 Freedom Broker lowered its price target from $160.00 to $150.00, maintaining a Buy rating.<\/p>\n<p><strong>BILL (BILL)<\/strong> \u2014 Truist Financial raised its price target from $50.00 to $58.00, maintaining a Hold rating.<\/p>\n<p><strong>BJ&#8217;s Wholesale Club (BJ)<\/strong> \u2014 Stifel Nicolaus initiated coverage with a Hold rating and a price target of $105.00.<\/p>\n<p><strong>BKV (BKV)<\/strong> \u2014 Citigroup raised its price target from $31.00 to $32.00, maintaining a Buy rating.<\/p>\n<p><strong>Bausch + Lomb (BLCO)<\/strong> \u2014 Barclays raised its price target from $24.00 to $27.00, maintaining an Overweight rating.<\/p>\n<p><strong>Ballard Power Systems (BLDP)<\/strong> \u2014 Raymond James Financial set a price target of $2.20, with a Market Perform rating.<\/p>\n<p><strong>Ballard Power Systems (BLDP)<\/strong> \u2014 KeyCorp maintained its Sector Weight rating.<\/p>\n<p><strong>BlackRock (BLK)<\/strong> \u2014 Mizuho initiated coverage with an Outperform rating and a price target of $1,450.00.<\/p>\n<p><strong>Bumble (BMBL)<\/strong> \u2014 Citigroup raised its price target from $3.20 to $6.05, maintaining a Neutral rating.<\/p>\n<p><strong>Baldwin Insurance Group (BWIN)<\/strong> \u2014 Raymond James Financial reiterated its coverage with a price target of $32.16.<\/p>\n<p><strong>Blackstone (BX)<\/strong> \u2014 Mizuho initiated coverage with an Outperform rating and a price target of $139.00.<\/p>\n<p><strong>Blackstone (BX)<\/strong> \u2014 Deutsche Bank maintained its Buy rating.<\/p>\n<p><strong>Blackstone (BX)<\/strong> \u2014 Royal Bank Of Canada raised its price target from $24.00 to $26.00, maintaining an Outperform rating.<\/p>\n<p><strong>Cardinal Health (CAH)<\/strong> \u2014 Wells Fargo &amp; Company raised its price target from $277.00 to $321.00, maintaining an Overweight rating.<\/p>\n<p><strong>Cars.com (CARS)<\/strong> \u2014 BTIG Research maintained its Buy rating with a price target of $16.00.<\/p>\n<p><strong>Casey&#8217;s General Stores (CASY)<\/strong> \u2014 Stifel Nicolaus initiated coverage with a Buy rating and a price target of $800.00.<\/p>\n<p><strong>Coastal Financial (CCB)<\/strong> \u2014 Raymond James Financial maintained its Outperform rating.<\/p>\n<p><strong>Crown Castle (CCI)<\/strong> \u2014 Deutsche Bank initiated coverage with a Hold rating and a price target of $96.00.<\/p>\n<p><strong>CG Oncology (CGON)<\/strong> \u2014 JPMorgan Chase &amp; Co. raised its price target from $96.00 to $113.00, maintaining an Overweight rating.<\/p>\n<p><strong>CG Oncology (CGON)<\/strong> \u2014 Royal Bank Of Canada downgraded the stock from Outperform to Sector Perform and raised its price target from $80.00 to $97.00.<\/p>\n<p><strong>CG Oncology (CGON)<\/strong> \u2014 HC Wainwright raised its price target from $100.00 to $115.00, maintaining a Buy rating.<\/p>\n<p><strong>CG Oncology (CGON)<\/strong> \u2014 Truist Financial raised its price target from $85.00 to $100.00, maintaining a Buy rating.<\/p>\n<p><strong>CG Oncology (CGON)<\/strong> \u2014 Wedbush raised its price target from $84.00 to $91.00, maintaining an Outperform rating.<\/p>\n<p><strong>Church &amp; Dwight (CHD)<\/strong> \u2014 Wells Fargo &amp; Company raised its price target from $115.00 to $125.00, maintaining an Overweight rating.<\/p>\n<p><strong>Chewy (CHWY)<\/strong> \u2014 Stifel Nicolaus initiated coverage with a Hold rating and a price target of $22.00.<\/p>\n<p><strong>Citizens (CIZN)<\/strong> \u2014 Citizens Jmp set a price target of $16.00.<\/p>\n<p><strong>Centene (CNC)<\/strong> \u2014 Sanford C. Bernstein maintained its Outperform rating.<\/p>\n<p><strong>Connect Biopharma (CNTB)<\/strong> \u2014 Canaccord Genuity Group maintained its Buy rating.<\/p>\n<p><strong>Cencora (COR)<\/strong> \u2014 Wells Fargo &amp; Company raised its price target from $395.00 to $400.00, maintaining an Overweight rating.<\/p>\n<p><strong>Costco Wholesale (COST)<\/strong> \u2014 Mizuho raised its price target from $1,100.00 to $1,150.00, maintaining an Outperform rating.<\/p>\n<p><strong>Costco Wholesale (COST)<\/strong> \u2014 Stifel Nicolaus initiated coverage with a Buy rating and a price target of $1,220.00.<\/p>\n<p><strong>Corebridge Financial (CRBG)<\/strong> \u2014 Mizuho raised its price target from $41.00 to $42.00, maintaining an Outperform rating.<\/p>\n<p><strong>Cisco Systems (CSCO)<\/strong> \u2014 HSBC upgraded the stock from Hold to Buy and raised its price target from $120.00 to $133.00.<\/p>\n<p><strong>Cisco Systems (CSCO)<\/strong> \u2014 DZ Bank upgraded the stock from Hold to Buy, with a price target of $125.00.<\/p>\n<p><strong>Carvana (CVNA)<\/strong> \u2014 Stifel Nicolaus initiated coverage with a Buy rating and a price target of $85.00.<\/p>\n<p><strong>Clearway Energy (CWEN)<\/strong> \u2014 Morgan Stanley raised its price target from $52.00 to $53.00, maintaining an Overweight rating.<\/p>\n<p><strong>Community Health Systems (CYH)<\/strong> \u2014 Royal Bank Of Canada lowered its price target from $4.00 to $3.00, maintaining an Outperform rating.<\/p>\n<p><strong>Cypherpunk Technologies (CYPH)<\/strong> \u2014 Cantor Fitzgerald raised its price target from $4.90 to $5.00, maintaining an Overweight rating.<\/p>\n<p><strong>Delta Air Lines (DAL)<\/strong> \u2014 UBS Group raised its price target from $102.00 to $113.00, maintaining a Buy rating.<\/p>\n<p><strong>Diageo (DEO)<\/strong> \u2014 TD Cowen maintained its Buy rating.<\/p>\n<p><strong>Definium Therapeutics (DFTX)<\/strong> \u2014 JPMorgan Chase &amp; Co. raised its price target from $84.00 to $85.00, maintaining an Overweight rating.<\/p>\n<p><strong>Dollar General (DG)<\/strong> \u2014 Stifel Nicolaus initiated coverage with a Hold rating and a price target of $145.00.<\/p>\n<p><strong>Dollar Tree (DLTR)<\/strong> \u2014 Stifel Nicolaus initiated coverage with a Buy rating and a price target of $160.00.<\/p>\n<p><strong>Alpha Tau Medical (DRTS)<\/strong> \u2014 HC Wainwright maintained its Buy rating with a price target of $16.00.<\/p>\n<p><strong>Alpha Tau Medical (DRTS)<\/strong> \u2014 UBS Group maintained its Buy rating.<\/p>\n<p><strong>Duos Technologies Group (DUOT)<\/strong> \u2014 Cantor Fitzgerald lowered its price target from $24.00 to $15.00, maintaining an Overweight rating.<\/p>\n<p><strong>Equifax (EFX)<\/strong> \u2014 BMO Capital Markets raised its price target from $175.00 to $186.00, maintaining a Market Perform rating.<\/p>\n<p><strong>Equifax (EFX)<\/strong> \u2014 Lake Street Capital downgraded the stock to Hold.<\/p>\n<p><strong>Everest Group (EG)<\/strong> \u2014 Morgan Stanley raised its price target from $395.00 to $425.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>EMCOR Group (EME)<\/strong> \u2014 Morgan Stanley initiated coverage with an Overweight rating and a price target of $799.00.<\/p>\n<p><strong>Emerson Electric (EMR)<\/strong> \u2014 Morgan Stanley raised its price target from $140.00 to $175.00, maintaining an Underweight rating.<\/p>\n<p><strong>Equitable (EQH)<\/strong> \u2014 Mizuho lowered its price target from $67.00 to $65.00, maintaining an Outperform rating.<\/p>\n<p><strong>Erasca (ERAS)<\/strong> \u2014 Leerink Partners initiated coverage with an Outperform rating and a price target of $35.00.<\/p>\n<p><strong>Elbit Systems (ESLT)<\/strong> \u2014 Jefferies Financial Group maintained its Hold rating.<\/p>\n<p><strong>Elastic (ESTC)<\/strong> \u2014 TD Cowen lowered its price target from $95.00 to $85.00, maintaining a Hold rating.<\/p>\n<p><strong>enCore Energy (EU)<\/strong> \u2014 B. Riley Financial lowered its price target from $2.50 to $1.75, maintaining a Buy rating.<\/p>\n<p><strong>Expeditors International of Washington (EXPD)<\/strong> \u2014 Barclays raised its price target from $175.00 to $200.00, maintaining an Underweight rating.<\/p>\n<p><strong>Diamondback Energy (FANG)<\/strong> \u2014 Truist Financial raised its price target from $232.00 to $242.00, maintaining a Buy rating.<\/p>\n<p><strong>Diamondback Energy (FANG)<\/strong> \u2014 Mizuho set a price target of $248.00.<\/p>\n<p><strong>Diamondback Energy (FANG)<\/strong> \u2014 Sanford C. Bernstein maintained its Market Perform rating.<\/p>\n<p><strong>FTAI Infrastructure (FIP)<\/strong> \u2014 JonesTrading set a price target of $8.75.<\/p>\n<p><strong>Five Below (FIVE)<\/strong> \u2014 Mizuho raised its price target from $295.00 to $300.00, maintaining an Outperform rating.<\/p>\n<p><strong>Five Below (FIVE)<\/strong> \u2014 Stifel Nicolaus initiated coverage with a Hold rating and a price target of $235.00.<\/p>\n<p><strong>Comfort Systems USA (FIX)<\/strong> \u2014 Morgan Stanley initiated coverage with an Overweight rating and a price target of $1,410.00.<\/p>\n<p><strong>Flex (FLEX)<\/strong> \u2014 Raymond James Financial set a price target of $150.00, with an Outperform rating.<\/p>\n<p><strong>Forgent Power Solutions (FPS)<\/strong> \u2014 Wells Fargo &amp; Company lowered its price target from $44.00 to $25.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Forum Markets (FRMM)<\/strong> \u2014 StoneX lowered its price target from $12.00 to $10.00, maintaining a Speculative Buy rating.<\/p>\n<p><strong>FitLife Brands (FTLF)<\/strong> \u2014 Lake Street Capital lowered its price target from $18.00 to $12.00, maintaining a Buy rating.<\/p>\n<p><strong>GCT Semiconductor (GCTS)<\/strong> \u2014 HC Wainwright initiated coverage with a Buy rating and a price target of $3.00.<\/p>\n<p><strong>GH Research (GHRS)<\/strong> \u2014 HC Wainwright lowered its price target from $7.00 to $3.00, maintaining a Buy rating.<\/p>\n<p><strong>Alphabet (GOOG)<\/strong> \u2014 UBS Group changed its rating from Neutral to Buy and lowered its price target from $380.00 to $320.00.<\/p>\n<p><strong>Genuine Parts (GPC)<\/strong> \u2014 Stifel Nicolaus initiated coverage with a Hold rating and a price target of $130.00.<\/p>\n<p><strong>Grindr (GRND)<\/strong> \u2014 Citizens Jmp raised its price target from $21.00 to $33.00, maintaining a Market Outperform rating.<\/p>\n<p><strong>Grindr (GRND)<\/strong> \u2014 Citigroup maintained its Market Outperform rating.<\/p>\n<p><strong>GXO Logistics (GXO)<\/strong> \u2014 Citigroup raised its price target from $66.00 to $71.00, maintaining a Buy rating.<\/p>\n<p><strong>GXO Logistics (GXO)<\/strong> \u2014 UBS Group raised its price target from $69.00 to $72.00, maintaining a Buy rating.<\/p>\n<p><strong>GXO Logistics (GXO)<\/strong> \u2014 Wells Fargo &amp; Company raised its price target from $65.00 to $75.00, maintaining an Overweight rating.<\/p>\n<p><strong>GXO Logistics (GXO)<\/strong> \u2014 Morgan Stanley raised its price target from $78.00 to $85.00, maintaining an Overweight rating.<\/p>\n<p><strong>GXO Logistics (GXO)<\/strong> \u2014 Stifel Nicolaus raised its price target from $72.00 to $79.00, maintaining a Buy rating.<\/p>\n<p><strong>HA Sustainable Infrastructure Capital (HASI)<\/strong> \u2014 Morgan Stanley raised its price target from $60.00 to $61.00, maintaining an Overweight rating.<\/p>\n<p><strong>Home Depot (HD)<\/strong> \u2014 TD Cowen maintained its Outperform rating.<\/p>\n<p><strong>Home Depot (HD)<\/strong> \u2014 Evercore maintained its Outperform rating.<\/p>\n<p><strong>Home Depot (HD)<\/strong> \u2014 TD Cowen set a price target of $410.00.<\/p>\n<p><strong>Hess Midstream Partners (HESM)<\/strong> \u2014 Morgan Stanley raised its price target from $30.00 to $32.00, maintaining an Underweight rating.<\/p>\n<p><strong>The Hartford Insurance Group (HIG)<\/strong> \u2014 Morgan Stanley raised its price target from $135.00 to $145.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Hallador Energy (HNRG)<\/strong> \u2014 B. Riley Financial lowered its price target from $29.00 to $27.00, maintaining a Buy rating.<\/p>\n<p><strong>Henry Schein (HSIC)<\/strong> \u2014 Morgan Stanley raised its price target from $64.00 to $68.00, maintaining an Underweight rating.<\/p>\n<p><strong>H World Group (HTHT)<\/strong> \u2014 StoneX raised its price target from $60.00 to $64.00, maintaining a Buy rating.<\/p>\n<p><strong>Humana (HUM)<\/strong> \u2014 Sanford C. Bernstein maintained its Outperform rating.<\/p>\n<p><strong>TuHURA Biosciences (HURA)<\/strong> \u2014 HC Wainwright maintained its Buy rating.<\/p>\n<p><strong>IDACORP (IDA)<\/strong> \u2014 Jefferies Financial Group downgraded the stock from Buy to Hold and raised its price target from $155.00 to $163.00.<\/p>\n<p><strong>IDEAYA Biosciences (IDYA)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating with a price target of $45.00.<\/p>\n<p><strong>Immatics (IMTX)<\/strong> \u2014 Jefferies Financial Group maintained its Buy rating.<\/p>\n<p><strong>Incyte (INCY)<\/strong> \u2014 Jefferies Financial Group set a price target of $115.00, with a Hold rating.<\/p>\n<p><strong>Infleqtion (INFQ)<\/strong> \u2014 Wedbush maintained its Outperform rating with a price target of $20.00.<\/p>\n<p><strong>Infleqtion (INFQ)<\/strong> \u2014 Canaccord Genuity Group lowered its price target from $22.00 to $17.00, maintaining a Buy rating.<\/p>\n<p><strong>Inter &amp; Co. Inc. (INTR)<\/strong> \u2014 JPMorgan Chase &amp; Co. lowered its price target from $11.00 to $7.50, maintaining an Overweight rating.<\/p>\n<p><strong>Intuit (INTU)<\/strong> \u2014 Wells Fargo &amp; Company raised its price target from $300.00 to $330.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>iQIYI (IQ)<\/strong> \u2014 New Street Research downgraded the stock from Buy to Neutral.<\/p>\n<p><strong>iQIYI (IQ)<\/strong> \u2014 StoneX maintained its Hold rating.<\/p>\n<p><strong>Ispire Technology (ISPR)<\/strong> \u2014 BTIG Research set a price target of $2.90, with a Buy rating.<\/p>\n<p><strong>Intuitive Surgical (ISRG)<\/strong> \u2014 BMO Capital Markets maintained its Outperform rating.<\/p>\n<p><strong>Invesco (IVZ)<\/strong> \u2014 Mizuho initiated coverage with an Outperform rating and a price target of $37.00.<\/p>\n<p><strong>JD.com (JD)<\/strong> \u2014 Jefferies Financial Group lowered its price target from $50.00 to $43.00, maintaining a Buy rating.<\/p>\n<p><strong>Jasper Therapeutics (JSPR)<\/strong> \u2014 Piper Sandler maintained its Overweight rating.<\/p>\n<p><strong>Kimco Realty (KIM)<\/strong> \u2014 BNP Paribas Exane initiated coverage with an Outperform rating and a price target of $29.00.<\/p>\n<p><strong>KKR &amp; Co. Inc. (KKR)<\/strong> \u2014 Mizuho initiated coverage with an Outperform rating and a price target of $116.00.<\/p>\n<p><strong>Kimberly-Clark (KMB)<\/strong> \u2014 JPMorgan Chase &amp; Co. initiated coverage with a Neutral rating and a price target of $113.00.<\/p>\n<p><strong>CarMax (KMX)<\/strong> \u2014 Stifel Nicolaus initiated coverage with a Hold rating and a price target of $55.00.<\/p>\n<p><strong>Kiniksa Pharmaceuticals International (KNSA)<\/strong> \u2014 TD Cowen raised its price target from $100.00 to $115.00, maintaining a Buy rating.<\/p>\n<p><strong>Coca-Cola (KO)<\/strong> \u2014 TD Cowen raised its price target from $104.00 to $112.00, maintaining a Buy rating.<\/p>\n<p><strong>Coca Cola FEMSA (KOF)<\/strong> \u2014 UBS Group raised its price target from $113.00 to $124.00, maintaining a Neutral rating.<\/p>\n<p><strong>Kroger (KR)<\/strong> \u2014 Stifel Nicolaus initiated coverage with a Buy rating and a price target of $80.00.<\/p>\n<p><strong>Kohl&#8217;s (KSS)<\/strong> \u2014 Telsey Advisory Group raised its price target from $18.00 to $25.00, maintaining a Market Perform rating.<\/p>\n<p><strong>Largo (LGO)<\/strong> \u2014 HC Wainwright maintained its Buy rating with a price target of $0.90.<\/p>\n<p><strong>Lumentum (LITE)<\/strong> \u2014 B. Riley Financial lowered its price target from $770.00 to $659.00, maintaining a Neutral rating.<\/p>\n<p><strong>Eli Lilly and Company (LLY)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating with a price target of $1,600.00.<\/p>\n<p><strong>Lumexa Imaging (LMRI)<\/strong> \u2014 Barclays raised its price target from $13.00 to $17.00, maintaining an Overweight rating.<\/p>\n<p><strong>Lincoln National (LNC)<\/strong> \u2014 Mizuho raised its price target from $50.00 to $51.00, maintaining an Outperform rating.<\/p>\n<p><strong>Athira Pharma (LONA)<\/strong> \u2014 Citizens Jmp lowered its price target from $17.00 to $16.00, maintaining a Market Outperform rating.<\/p>\n<p><strong>Southwest Airlines (LUV)<\/strong> \u2014 UBS Group raised its price target from $54.00 to $59.00, maintaining a Buy rating.<\/p>\n<p><strong>Lightwave Logic (LWLG)<\/strong> \u2014 Freedom Broker maintained its Buy rating.<\/p>\n<p><strong>Mobileye Global (MBLY)<\/strong> \u2014 Citigroup lowered its price target from $11.00 to $10.00, maintaining a Buy rating.<\/p>\n<p><strong>Microbot Medical (MBOT)<\/strong> \u2014 Citigroup maintained its Market Outperform rating.<\/p>\n<p><strong>Microbot Medical (MBOT)<\/strong> \u2014 Citizens Jmp lowered its price target from $2.50 to $2.00, maintaining a Market Outperform rating.<\/p>\n<p><strong>Medtronic (MDT)<\/strong> \u2014 Piper Sandler upgraded the stock from Neutral to Overweight and raised its price target from $85.00 to $120.00.<\/p>\n<p><strong>Medtronic (MDT)<\/strong> \u2014 TD Cowen set a price target of $110.00, with a Buy rating.<\/p>\n<p><strong>MiMedx Group (MDXG)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating with a price target of $8.00.<\/p>\n<p><strong>Meta Platforms (META)<\/strong> \u2014 UBS Group initiated coverage with a Buy rating and a price target of $815.00.<\/p>\n<p><strong>Mosaic (MOS)<\/strong> \u2014 UBS Group raised its price target from $19.00 to $22.00, maintaining a Neutral rating.<\/p>\n<p><strong>Maplight Therapeutics (MPLT)<\/strong> \u2014 Canaccord Genuity Group maintained its Buy rating with a price target of $21.00.<\/p>\n<p><strong>Moderna (MRNA)<\/strong> \u2014 JPMorgan Chase &amp; Co. raised its price target from $77.00 to $102.00, maintaining an Underweight rating.<\/p>\n<p><strong>Moderna (MRNA)<\/strong> \u2014 Morgan Stanley raised its price target from $95.00 to $200.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>MasTec (MTZ)<\/strong> \u2014 Morgan Stanley initiated coverage with an Equal Weight rating and a price target of $220.00.<\/p>\n<p><strong>Murphy USA (MUSA)<\/strong> \u2014 Stifel Nicolaus initiated coverage with a Hold rating and a price target of $545.00.<\/p>\n<p><strong>NCR Atleos (NATL)<\/strong> \u2014 DA Davidson maintained its Neutral rating with a price target of $50.00.<\/p>\n<p><strong>NewJersey Resources (NJR)<\/strong> \u2014 Jefferies Financial Group lowered its price target from $56.00 to $54.00, maintaining a Hold rating.<\/p>\n<p><strong>Neumora Therapeutics (NMRA)<\/strong> \u2014 Guggenheim maintained its Buy rating.<\/p>\n<p><strong>Nutanix (NTNX)<\/strong> \u2014 Rosenblatt Securities maintained its Buy rating with a price target of $75.00.<\/p>\n<p><strong>Netskope (NTSK)<\/strong> \u2014 Rosenblatt Securities raised its price target from $19.00 to $28.00, maintaining a Buy rating.<\/p>\n<p><strong>Nucor (NUE)<\/strong> \u2014 Morgan Stanley upgraded the stock from Equal Weight to Overweight and raised its price target from $300.00 to $310.00.<\/p>\n<p><strong>Nuvation Bio (NUVB)<\/strong> \u2014 HC Wainwright maintained its Buy rating with a price target of $21.00.<\/p>\n<p><strong>Nextpower (NXT)<\/strong> \u2014 JPMorgan Chase &amp; Co. lowered its price target from $134.00 to $133.00, maintaining an Overweight rating.<\/p>\n<p><strong>Nextpower (NXT)<\/strong> \u2014 BMO Capital Markets lowered its price target from $114.00 to $108.00, maintaining an Outperform rating.<\/p>\n<p><strong>Nextpower (NXT)<\/strong> \u2014 Truist Financial set a price target of $145.00.<\/p>\n<p><strong>Nextpower (NXT)<\/strong> \u2014 Citigroup maintained its Buy rating.<\/p>\n<p><strong>Oculis (OCS)<\/strong> \u2014 HC Wainwright maintained its Buy rating with a price target of $39.00.<\/p>\n<p><strong>Ocular Therapeutix (OCUL)<\/strong> \u2014 HC Wainwright maintained its Buy rating with a price target of $28.00.<\/p>\n<p><strong>Okta (OKTA)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating with a price target of $250.00.<\/p>\n<p><strong>Omeros (OMER)<\/strong> \u2014 HC Wainwright maintained its Buy rating with a price target of $33.00.<\/p>\n<p><strong>OneWater Marine (ONEW)<\/strong> \u2014 Raymond James Financial maintained its Market Perform rating.<\/p>\n<p><strong>Oric Pharmaceuticals (ORIC)<\/strong> \u2014 Wedbush maintained its Outperform rating.<\/p>\n<p><strong>Oric Pharmaceuticals (ORIC)<\/strong> \u2014 Citigroup raised its price target from $16.00 to $17.00, maintaining a Buy rating.<\/p>\n<p><strong>Oric Pharmaceuticals (ORIC)<\/strong> \u2014 BTIG Research maintained its Buy rating with a price target of $26.00.<\/p>\n<p><strong>O&#8217;Reilly Automotive (ORLY)<\/strong> \u2014 Stifel Nicolaus initiated coverage with a Buy rating and a price target of $105.00.<\/p>\n<p><strong>Penske Automotive Group (PAG)<\/strong> \u2014 Citigroup raised its price target from $210.00 to $212.00, maintaining a Neutral rating.<\/p>\n<p><strong>Plains GP (PAGP)<\/strong> \u2014 Morgan Stanley lowered its price target from $28.00 to $27.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Palo Alto Networks (PANW)<\/strong> \u2014 Guggenheim maintained its Neutral rating.<\/p>\n<p><strong>Petroleo Brasileiro S.A. &#8211; Petrobras (PBR)<\/strong> \u2014 Citigroup lowered its price target from $21.50 to $18.50, maintaining a Neutral rating.<\/p>\n<p><strong>PagerDuty (PD)<\/strong> \u2014 Truist Financial raised its price target from $15.00 to $17.00, maintaining a Buy rating.<\/p>\n<p><strong>Penumbra (PEN)<\/strong> \u2014 Canaccord Genuity Group maintained its Hold rating with a price target of $374.00.<\/p>\n<p><strong>PepsiCo (PEP)<\/strong> \u2014 Sanford C. Bernstein downgraded the stock from Market Perform to Underperform and lowered its price target from $131.00 to $128.00.<\/p>\n<p><strong>Progyny (PGNY)<\/strong> \u2014 Truist Financial raised its price target from $36.00 to $42.00, maintaining a Buy rating.<\/p>\n<p><strong>Progressive (PGR)<\/strong> \u2014 Morgan Stanley raised its price target from $210.00 to $235.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Parker-Hannifin (PH)<\/strong> \u2014 Morgan Stanley lowered its price target from $16.00 to $9.00, maintaining an Outperform rating.<\/p>\n<p><strong>Pulse Biosciences (PLSE)<\/strong> \u2014 Needham &amp; Company LLC maintained its Buy rating.<\/p>\n<p><strong>Philip Morris International (PM)<\/strong> \u2014 BTIG Research set a price target of $225.00, with a Buy rating.<\/p>\n<p><strong>The Pennant Group (PNTG)<\/strong> \u2014 Wells Fargo &amp; Company raised its price target from $46.00 to $49.00, maintaining an Overweight rating.<\/p>\n<p><strong>Pool (POOL)<\/strong> \u2014 DA Davidson maintained its Neutral rating with a price target of $200.00.<\/p>\n<p><strong>People Incorporated Common Stock (PPLI)<\/strong> \u2014 Truist Financial set a price target of $59.00.<\/p>\n<p><strong>Perpetua Resources (PPTA)<\/strong> \u2014 HC Wainwright maintained its Buy rating with a price target of $43.50.<\/p>\n<p><strong>Praxis Precision Medicines (PRAX)<\/strong> \u2014 Wells Fargo &amp; Company changed its rating from Positive to Overweight and raised its price target from $343.00 to $509.00.<\/p>\n<p><strong>PROG (PRG)<\/strong> \u2014 Loop Capital downgraded the stock from Buy to Hold, with a price target of $40.00.<\/p>\n<p><strong>Quanta Services (PWR)<\/strong> \u2014 Morgan Stanley initiated coverage with an Equal Weight rating and a price target of $636.00.<\/p>\n<p><strong>Rubrik (RBRK)<\/strong> \u2014 Oppenheimer raised its price target from $120.00 to $150.00, maintaining an Outperform rating.<\/p>\n<p><strong>Rubrik (RBRK)<\/strong> \u2014 Cantor Fitzgerald raised its price target from $120.00 to $125.00, maintaining an Overweight rating.<\/p>\n<p><strong>Red Cat (RCAT)<\/strong> \u2014 Piper Sandler lowered its price target from $6.00 to $3.00, maintaining a Neutral rating.<\/p>\n<p><strong>Red Cat (RCAT)<\/strong> \u2014 HC Wainwright lowered its price target from $20.00 to $10.00, maintaining a Buy rating.<\/p>\n<p><strong>Red Cat (RCAT)<\/strong> \u2014 Needham &amp; Company LLC lowered its price target from $15.00 to $5.00, maintaining a Buy rating.<\/p>\n<p><strong>Rocket Pharmaceuticals (RCKT)<\/strong> \u2014 Chardan Capital maintained its Buy rating with a price target of $11.00.<\/p>\n<p><strong>Regeneron Pharmaceuticals (REGN)<\/strong> \u2014 Barclays raised its price target from $917.00 to $1,075.00, maintaining an Overweight rating.<\/p>\n<p><strong>Rivian Automotive (RIVN)<\/strong> \u2014 StoneX lowered its price target from $25.00 to $20.00, maintaining a Buy rating.<\/p>\n<p><strong>RenaissanceRe (RNR)<\/strong> \u2014 Morgan Stanley raised its price target from $335.00 to $365.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Rapid Micro Biosystems (RPID)<\/strong> \u2014 Roth Capital downgraded the stock from Buy to Neutral and lowered its price target from $3.00 to $0.75.<\/p>\n<p><strong>Rapid Micro Biosystems (RPID)<\/strong> \u2014 JPMorgan Chase &amp; Co. set a price target of $0.75.<\/p>\n<p><strong>Range Resources (RRC)<\/strong> \u2014 Susquehanna raised its price target from $44.00 to $52.00, maintaining a Neutral rating.<\/p>\n<p><strong>Revolution Medicines (RVMD)<\/strong> \u2014 HC Wainwright maintained its Buy rating with a price target of $350.00.<\/p>\n<p><strong>Redwood Trust (RWT)<\/strong> \u2014 BTIG Research lowered its price target from $5.00 to $4.50, maintaining a Buy rating.<\/p>\n<p><strong>Rezolute (RZLT)<\/strong> \u2014 Wedbush raised its price target from $6.00 to $10.00, maintaining an Outperform rating.<\/p>\n<p><strong>Rezolve AI (RZLV)<\/strong> \u2014 HC Wainwright initiated coverage with a Buy rating and a price target of $6.00.<\/p>\n<p><strong>SBA Communications (SBAC)<\/strong> \u2014 Deutsche Bank initiated coverage with a Hold rating and a price target of $211.00.<\/p>\n<p><strong>Stellus Capital Investment (SCM)<\/strong> \u2014 Keefe, Bruyette &amp; Woods lowered its price target from $8.00 to $7.50, maintaining a Market Perform rating.<\/p>\n<p><strong>Sprouts Farmers Market (SFM)<\/strong> \u2014 B. Riley Financial lowered its price target from $109.00 to $45.00, maintaining an Overweight rating.<\/p>\n<p><strong>Shoals Technologies Group (SHLS)<\/strong> \u2014 UBS Group downgraded the stock from Buy to Neutral and lowered its price target from $12.00 to $9.00.<\/p>\n<p><strong>Selective Insurance Group (SIGI)<\/strong> \u2014 Morgan Stanley raised its price target from $85.00 to $90.00, maintaining an Underweight rating.<\/p>\n<p><strong>Skydance (SKYD)<\/strong> \u2014 Freedom Broker lowered its price target from $10.00 to $8.50, maintaining a Hold rating.<\/p>\n<p><strong>Slide Insurance (SLDE)<\/strong> \u2014 Morgan Stanley raised its price target from $24.00 to $27.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Soluna (SLNH)<\/strong> \u2014 Rosenblatt Securities maintained its Buy rating with a price target of $2.00.<\/p>\n<p><strong>SharkNinja (SN)<\/strong> \u2014 Stifel Nicolaus initiated coverage with a Buy rating and a price target of $255.00.<\/p>\n<p><strong>Snowflake (SNOW)<\/strong> \u2014 BTIG Research maintained its Buy rating with a price target of $424.00.<\/p>\n<p><strong>TD SYNNEX (SNX)<\/strong> \u2014 Barclays lowered its price target from $287.00 to $282.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>SoundHound AI (SOUN)<\/strong> \u2014 HC Wainwright initiated coverage with a Buy rating and a price target of $7.00.<\/p>\n<p><strong>SpaceX (SPCX)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating with a price target of $345.00.<\/p>\n<p><strong>Simon Property Group (SPG)<\/strong> \u2014 Citigroup raised its price target from $230.00 to $237.00, maintaining a Neutral rating.<\/p>\n<p><strong>Spire (SR)<\/strong> \u2014 BTIG Research maintained its Buy rating.<\/p>\n<p><strong>Stellantis (STLA)<\/strong> \u2014 Oddo Bhf downgraded the stock from Neutral to Underperform, with a price target of $3.30.<\/p>\n<p><strong>Steel Dynamics (STLD)<\/strong> \u2014 Morgan Stanley raised its price target from $260.00 to $270.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Stanley Black &amp; Decker (SWK)<\/strong> \u2014 Mizuho downgraded the stock from Outperform to Neutral and raised its price target from $105.00 to $120.00.<\/p>\n<p><strong>Sysco (SYY)<\/strong> \u2014 Guggenheim maintained its Buy rating.<\/p>\n<p><strong>Teva Pharmaceutical Industries (TEVA)<\/strong> \u2014 Argus raised its price target from $42.00 to $50.00, maintaining a Buy rating.<\/p>\n<p><strong>Teva Pharmaceutical Industries (TEVA)<\/strong> \u2014 HC Wainwright maintained its Buy rating with a price target of $54.00.<\/p>\n<p><strong>Target (TGT)<\/strong> \u2014 Stifel Nicolaus initiated coverage with a Hold rating and a price target of $155.00.<\/p>\n<p><strong>TIM (TIMB)<\/strong> \u2014 Itau BBA Securities upgraded the stock from Market Perform to Outperform.<\/p>\n<p><strong>TIM (TIMB)<\/strong> \u2014 Bank of America downgraded the stock from Buy to Neutral, with a price target of $21.00.<\/p>\n<p><strong>T-Mobile US (TMUS)<\/strong> \u2014 Citigroup raised its price target from $165.00 to $185.00, maintaining a Neutral rating.<\/p>\n<p><strong>Turning Point Brands (TPB)<\/strong> \u2014 Compass Point set a price target of $101.00.<\/p>\n<p><strong>Turning Point Brands (TPB)<\/strong> \u2014 BTIG Research maintained its Buy rating.<\/p>\n<p><strong>TPG (TPG)<\/strong> \u2014 Mizuho initiated coverage with a Neutral rating and a price target of $52.00.<\/p>\n<p><strong>T. Rowe Price Group (TROW)<\/strong> \u2014 Mizuho initiated coverage with a Underperform rating and a price target of $94.00.<\/p>\n<p><strong>Tractor Supply (TSCO)<\/strong> \u2014 Stifel Nicolaus initiated coverage with a Hold rating and a price target of $35.00.<\/p>\n<p><strong>Tesla (TSLA)<\/strong> \u2014 Barclays maintained its Overweight rating.<\/p>\n<p><strong>Tyson Foods (TSN)<\/strong> \u2014 Sanford C. Bernstein raised its price target from $66.00 to $72.00, maintaining a Market Perform rating.<\/p>\n<p><strong>Tyson Foods (TSN)<\/strong> \u2014 BMO Capital Markets raised its price target from $65.00 to $75.00, maintaining an Outperform rating.<\/p>\n<p><strong>Tyson Foods (TSN)<\/strong> \u2014 JPMorgan Chase &amp; Co. downgraded the stock from Overweight to Neutral and raised its price target from $63.00 to $65.00.<\/p>\n<p><strong>Tyson Foods (TSN)<\/strong> \u2014 Piper Sandler raised its price target from $56.00 to $72.00, maintaining an Overweight rating.<\/p>\n<p><strong>United Airlines (UAL)<\/strong> \u2014 UBS Group raised its price target from $139.00 to $147.00, maintaining a Buy rating.<\/p>\n<p><strong>Frontier Group (ULCC)<\/strong> \u2014 UBS Group raised its price target from $7.00 to $8.00, maintaining a Neutral rating.<\/p>\n<p><strong>United Natural Foods (UNFI)<\/strong> \u2014 The Goldman Sachs Group upgraded the stock from Neutral to Buy and raised its price target from $49.00 to $60.00.<\/p>\n<p><strong>US Foods (USFD)<\/strong> \u2014 JPMorgan Chase &amp; Co. raised its price target from $98.00 to $110.00, maintaining a Neutral rating.<\/p>\n<p><strong>VEON (VEON)<\/strong> \u2014 StoneX raised its price target from $85.00 to $92.00, maintaining a Buy rating.<\/p>\n<p><strong>Veritone (VERI)<\/strong> \u2014 Needham &amp; Company LLC maintained its Buy rating.<\/p>\n<p><strong>Vistra (VST)<\/strong> \u2014 Sanford C. Bernstein raised its price target from $181.00 to $182.00, maintaining an Outperform rating.<\/p>\n<p><strong>Vistra (VST)<\/strong> \u2014 BMO Capital Markets raised its price target from $188.00 to $196.00, maintaining an Outperform rating.<\/p>\n<p><strong>Victoria&#8217;s Secret &amp; Co. (VSXY)<\/strong> \u2014 BMO Capital Markets raised its price target from $80.00 to $100.00, maintaining a Market Perform rating.<\/p>\n<p><strong>Wayfair (W)<\/strong> \u2014 Guggenheim maintained its Buy rating.<\/p>\n<p><strong>Wayfair (W)<\/strong> \u2014 Stifel Nicolaus initiated coverage with a Hold rating and a price target of $120.00.<\/p>\n<p><strong>WBI (WBI)<\/strong> \u2014 Morgan Stanley lowered its price target from $43.00 to $41.00, maintaining an Overweight rating.<\/p>\n<p><strong>Workday (WDAY)<\/strong> \u2014 Piper Sandler set a price target of $190.00, with a Neutral rating.<\/p>\n<p><strong>Workday (WDAY)<\/strong> \u2014 UBS Group maintained its Neutral rating.<\/p>\n<p><strong>Western Midstream Partners (WES)<\/strong> \u2014 Morgan Stanley lowered its price target from $52.00 to $50.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Walmart (WMT)<\/strong> \u2014 Stifel Nicolaus initiated coverage with a Buy rating and a price target of $145.00.<\/p>\n<p><strong>W.R. Berkley (WRB)<\/strong> \u2014 Morgan Stanley raised its price target from $70.00 to $80.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Williams-Sonoma (WSM)<\/strong> \u2014 Barclays raised its price target from $190.00 to $240.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Williams-Sonoma (WSM)<\/strong> \u2014 Stifel Nicolaus initiated coverage with a Buy rating and a price target of $290.00.<\/p>\n<p><strong>Xenon Pharmaceuticals (XENE)<\/strong> \u2014 JPMorgan Chase &amp; Co. lowered its price target from $82.00 to $80.00, maintaining an Overweight rating.<\/p>\n<p><strong>XPLR Infrastructure (XIFR)<\/strong> \u2014 Morgan Stanley lowered its price target from $11.00 to $9.00, maintaining an Underweight rating.<\/p>\n<p><strong>XPENG (XPEV)<\/strong> \u2014 Freedom Broker lowered its price target from $22.00 to $20.00, maintaining a Buy rating.<\/p>\n<p><strong>XPENG (XPEV)<\/strong> \u2014 Sanford C. Bernstein lowered its price target from $18.00 to $15.00, maintaining a Market Perform rating.<\/p>\n<p><strong>Zimmer Biomet (ZBH)<\/strong> \u2014 Wells Fargo &amp; Company upgraded the stock from Equal Weight to Overweight and raised its price target from $113.00 to $123.00.<\/p>\n<p><strong>Zoom Communications (ZM)<\/strong> \u2014 Citigroup raised its price target from $126.00 to $131.00, maintaining a Buy rating.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Analyst Ratings (USA) American Airlines Group (AAL) \u2014 UBS Group raised its price target from $16.00 to $17.00, maintaining a Buy rating. Advance Auto&hellip;<\/p>\n","protected":false},"author":3,"featured_media":34576,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-77162","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v19.4 (Yoast SEO v21.4) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>American Analyst Ratings Updates: November 17th, 2026 | Stock Target Advisor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-17th-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"American Analyst Ratings Updates: November 17th, 2026\" \/>\n<meta property=\"og:description\" content=\"Analyst Ratings (USA) American Airlines Group (AAL) \u2014 UBS Group raised its price target from $16.00 to $17.00, maintaining a Buy rating. Advance Auto&hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-17th-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Stock Target Advisor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-18T03:28:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2023\/05\/Frame-7-6-2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"STA Research\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:site\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"STA Research\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"22 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-17th-2026\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-17th-2026\/\"},\"author\":{\"name\":\"STA Research\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\"},\"headline\":\"American Analyst Ratings Updates: November 17th, 2026\",\"datePublished\":\"2026-11-18T03:28:56+00:00\",\"dateModified\":\"2026-11-18T03:28:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-17th-2026\/\"},\"wordCount\":4424,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"articleSection\":[\"Market News &amp; Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-17th-2026\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-17th-2026\/\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-17th-2026\/\",\"name\":\"American Analyst Ratings Updates: November 17th, 2026 | Stock Target Advisor\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\"},\"datePublished\":\"2026-11-18T03:28:56+00:00\",\"dateModified\":\"2026-11-18T03:28:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-17th-2026\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-17th-2026\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-17th-2026\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"American Analyst Ratings Updates: November 17th, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"name\":\"Stock Target Advisor\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\",\"name\":\"Stock Target Advisor\",\"alternateName\":\"STA\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"contentUrl\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"width\":\"225\",\"height\":\"225\",\"caption\":\"Stock Target Advisor\"},\"image\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\",\"https:\/\/twitter.com\/AdvisorTarget\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\",\"name\":\"STA Research\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"caption\":\"STA Research\"},\"description\":\"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"American Analyst Ratings Updates: November 17th, 2026 | Stock Target Advisor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-17th-2026\/","og_locale":"en_US","og_type":"article","og_title":"American Analyst Ratings Updates: November 17th, 2026","og_description":"Analyst Ratings (USA) American Airlines Group (AAL) \u2014 UBS Group raised its price target from $16.00 to $17.00, maintaining a Buy rating. Advance Auto&hellip;","og_url":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-17th-2026\/","og_site_name":"Stock Target Advisor","article_publisher":"https:\/\/www.facebook.com\/StockTargetAdvisor\/","article_published_time":"2026-11-18T03:28:56+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2023\/05\/Frame-7-6-2.png","type":"image\/png"}],"author":"STA Research","twitter_card":"summary_large_image","twitter_creator":"@AdvisorTarget","twitter_site":"@AdvisorTarget","twitter_misc":{"Written by":"STA Research","Est. reading time":"22 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-17th-2026\/#article","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-17th-2026\/"},"author":{"name":"STA Research","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae"},"headline":"American Analyst Ratings Updates: November 17th, 2026","datePublished":"2026-11-18T03:28:56+00:00","dateModified":"2026-11-18T03:28:56+00:00","mainEntityOfPage":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-17th-2026\/"},"wordCount":4424,"commentCount":0,"publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"articleSection":["Market News &amp; Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-17th-2026\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-17th-2026\/","url":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-17th-2026\/","name":"American Analyst Ratings Updates: November 17th, 2026 | Stock Target Advisor","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website"},"datePublished":"2026-11-18T03:28:56+00:00","dateModified":"2026-11-18T03:28:56+00:00","breadcrumb":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-17th-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-17th-2026\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-17th-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.stocktargetadvisor.com\/blog\/"},{"@type":"ListItem","position":2,"name":"American Analyst Ratings Updates: November 17th, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","name":"Stock Target Advisor","description":"","publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization","name":"Stock Target Advisor","alternateName":"STA","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/","url":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","contentUrl":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","width":"225","height":"225","caption":"Stock Target Advisor"},"image":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StockTargetAdvisor\/","https:\/\/twitter.com\/AdvisorTarget"]},{"@type":"Person","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae","name":"STA Research","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","caption":"STA Research"},"description":"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.","url":"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/"}]}},"_links":{"self":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/77162","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/comments?post=77162"}],"version-history":[{"count":1,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/77162\/revisions"}],"predecessor-version":[{"id":77164,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/77162\/revisions\/77164"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media\/34576"}],"wp:attachment":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media?parent=77162"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/categories?post=77162"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/tags?post=77162"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}